Clinical Trials for End Stage Renal Disease With Renal Transplant

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

NCT ID: NCT07053462

This clinical trial is testing a new way to help people with severe kidney failure who need a transplant. In this study, donor kidneys are specially edited using a gene-editing tool called CRISPR b...